$103.42
-0.93 (-0.89%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+204.53%
1Y
+578.61%
YTD
+238.19%
Open$102.39
Previous Close$104.35
Day High$106.75
Day Low$101.64
52W High$105.09
52W Low$14.51
Volume—
Avg Volume891.3K
Market Cap8.54B
P/E Ratio—
EPS$-2.50
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$33.24
Above
SMA 200
$22.06
Above
RSI (14)
64.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
23 analysts
Price Target
-23.7% upside
Current
$103.42
$103.42
Target
$78.92
$78.92
$58.92
$78.92 avg
$128.60
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 469.29M | 433.92M | 481.69M |
| Net Income | -23,759,261 | -24,167,490 | -23,392,315 |
| Profit Margin | -5.1% | -5.6% | -4.9% |
| EBITDA | -33,340,073 | -28,197,061 | -36,465,134 |
| Free Cash Flow | -26,670,161 | -19,444,681 | -29,871,207 |
| Rev Growth | +18.1% | +19.4% | +22.5% |
| Debt/Equity | 0.73 | 0.87 | 0.77 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $244.33 | -0.76% | 122.9 | 446.67B |
| AMGN | Amgen Inc | $403.48 | -1.07% | 26.5 | 206.48B |
| GILD | Gilead Sciences Inc | $129.97 | -1.36% | 17.6 | 161.72B |
| VRTX | Vertex Pharmaceuticals Inc | $484.53 | -0.06% | 27.8 | 120.52B |
| REGN | Regeneron Pharmaceuticals | $767.54 | -0.14% | 17.5 | 77.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $217.83 | -4.76% | 47.7 | 27.52B |